CA-17-QL18_0.01uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=0.01uM, (2S)-4-cyclohexyl-2-[[1-[(4-nitrophenyl)methyl]-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]amino]butanoic acid, Angiotensin AT2 Antagonists targeting AGTR2 (Novartis, 22878749)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/22878749
Similar Terms
Downloads & Tools

Genes

7 genes differentially expressed following the CA-17-QL18_0.01uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
OAZ1 ornithine decarboxylase antizyme 1 0.903168
MYL6 myosin, light chain 6, alkali, smooth muscle and non-muscle 0.290167
XKR7 XK, Kell blood group complex subunit-related family, member 7 0.278278
ARF1 ADP-ribosylation factor 1 0.250202
MYH6 myosin, heavy chain 6, cardiac muscle, alpha 0.23439
CNN3 calponin 3, acidic 0.232743

decreased expression

Symbol Name Standardized Value
KHDC1 KH homology domain containing 1 -0.250202